ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01687608
Recruitment Status : Active, not recruiting
First Posted : September 19, 2012
Last Update Posted : November 8, 2017
Sponsor:
Information provided by (Responsible Party):
Shire ( Baxalta now part of Shire )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 28, 2030
  Estimated Study Completion Date : October 28, 2030